Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 6, 2007
app pub date -
Jan 9, 2007
filing date -
Jan 10, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention provides methods for treating cancer cells overexpressing Her-2/neu, the product of the erbB-2 gene, comprising administering a therapeutically effective amount of an unsaturated fatty acid. The cancer cells amenable to treatment exhibit relatively elevated activity levels of fatty acid synthase. Exemplary fatty acids useful in the methods of the invention include .omega.-9 monounsaturated fatty acids (e.g., oleic acid), .omega.-6 polyunsaturated fatty acids (e.g., .gamma.-linolenic acid) and .omega.-3 polyunsaturated fatty acids (e.g., .alpha.-linolenic acid). The invention also provides methods of preventing cancer comprising administering a prophylactically effective amount of a fatty acid and kits for preventing and/or treating cancer comprising a fatty acid and a conventional anti-cancer therapeutic.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully